VNJ Volume 40 (6) December 2025 | Page 81

N1033787
• Presenting problem
• Positioning in scanner
• Admit body temperature
• Pre-medication agent, dose, time, and route of administration
• Induction agent, dose, and time of administration
• Body temperature before entering MRI suite
• Body temperature after leaving MRI suite
• Temperature change during scan
• Heating aids used
• Scan time( minutes). The patients ages ranged from four months to twelve years with a variety of 36 breeds, ranging from 3.6-60kg in weight. For data analysis, dogs were arranged into the following age brackets:
• 0-1yr
• 1yr 1m – 3yr
• 3yr 1m – 7yr
• 7yr 1m – 10yr
• 10yr 1m +. 3.4 Drugs
The anaesthetic plans were catered individually to each patient, considering what condition they presented with, and other influencing factors such as age, temperament, concurrent medications, previous GAs, and other underlying health conditions. Following a clinical examination and a discussion with the anaesthetist, the anaesthetic plans( including premedication and induction agent) were created. Premedication choices were combinations of opioids, alpha-2 agonists, acepromazine( ACP), midazolam, lidocaine, and ketamine, and administered either intramuscularly( IM) or intravenously( IV). The following premedication combinations were used:
• Opioid & Alpha-2 agonist
• Opioid & ACP
• Opioid alone
• Opioid, Alpha-2 agonist & ACP
ANIM32126 – EBVN Project 15